Stock-Based Compensation | 5. Stock-Based Compensation The compensation costs that have been charged against income for the thirteen and thirty-nine weeks ended October 31, 2015 and November 1, 2014 were as follows (in thousands): Thirteen Weeks Ended Thirty-Nine Weeks Ended October 31, 2015 November 1, 2014 October 31, 2015 November 1, 2014 Stock-based compensation expense by type: Stock options $ 16 $ 19 $ 375 $ 449 Restricted stock unit awards, including performance-based 815 122 3,980 3,059 Employee stock purchases 23 25 81 81 Director deferred compensation 18 18 53 52 Total stock-based compensation expense 872 184 4,489 3,641 Income tax benefit recognized 316 60 1,645 1,342 Stock-based compensation expense, net of income tax $ 556 $ 124 $ 2,844 $ 2,299 In the thirteen and thirty-nine weeks ended October 31, 2015 and November 1, 2014, we granted the following equity awards: Thirteen Weeks Ended Thirty-Nine Weeks Ended October 31, 2015 November 1, 2014 October 31, 2015 November 1, 2014 Stock options 1,515 1,244 21,743 19,219 Restricted stock unit awards - - 69,529 63,399 Performance-based restricted stock unit awards - - 29,300 25,300 Deferred stock units 500 411 12,128 10,740 Under the 2012 Non-Employee Director Equity Plan (2012 Plan), no shares of our common stock were awarded during the thirteen weeks ended October 31, 2015 and November 1, 2014. A total of 1,981 and 1,759 shares of our common stock were awarded during the thirty-nine weeks ended October 31, 2015 and November 1, 2014, respectively, as part of the annual equity award to directors in the first quarter. In addition, under our employee stock purchase plan, our employees purchased 3,114 and 2,115 shares of our common stock during the thirteen weeks ended October 31, 2015 and November 1, 2014, respectively, and 8,605 and 6,796 shares of our common stock during the thirty-nine weeks ended October 31, 2015 and November 1, 2014, respectively. The weighted-average grant date fair value of stock options granted during the thirteen and thirty-nine weeks ended October 31, 2015 was $10.52 and $17.23 per share, respectively. The weighted-average grant date fair value of shares of stock purchased through our employee stock purchase plan was $10.01 and $10.35, and the weighted-average price paid by our employees for shares of our common stock was $29.76 and $36.66, during the thirteen and thirty-nine weeks ended October 31, 2015, respectively. The weighted-average grant date fair value of stock options granted during the thirteen and thirty-nine weeks ended November 1, 2014 was $15.36 and $23.38 per share, respectively. The weighted-average grant date fair value of shares of stock purchased through our employee stock purchase plan was $9.50 and $11.16, and the weighted-average price paid by our employees for shares of our common stock was $36.24 and $42.35, during the thirteen and thirty-nine weeks ended November 1, 2014, respectively. At October 31, 2015, the total compensation costs related to nonvested restricted stock unit awards not yet recognized was $8.6 million and the weighted-average period over which such awards are expected to be recognized was 2.5 years. There are no future compensation costs related to nonvested stock options to be recognized at October 31, 2015. |